Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
12.77
+0.19 (1.51%)
At close: Feb 9, 2026, 4:00 PM EST
12.78
+0.01 (0.08%)
After-hours: Feb 9, 2026, 4:00 PM EST
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 427 employees as of December 31, 2024. The number of employees decreased by 25 or -5.53% compared to the previous year.
Employees
427
Change (1Y)
-25
Growth (1Y)
-5.53%
Revenue / Employee
$344,707
Profits / Employee
-$642,974
Market Cap
999.82M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 427 | -25 | -5.53% |
| Dec 31, 2023 | 452 | 340 | 303.57% |
| Dec 31, 2022 | 112 | 35 | 45.45% |
| Dec 31, 2021 | 77 | 22 | 40.00% |
| Dec 31, 2020 | 55 | 30 | 120.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Iovance Biotherapeutics | 838 |
| Vir Biotechnology | 408 |
| UroGen Pharma | 287 |
| Geron | 229 |
| ARS Pharmaceuticals | 167 |
| CytomX Therapeutics | 121 |
| ORIC Pharmaceuticals | 106 |
| Nanobiotix | 103 |
PHAT News
- 4 days ago - Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026 - GlobeNewsWire
- 4 weeks ago - Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 4 weeks ago - Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 4 weeks ago - Phathom Pharmaceuticals Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Phathom Pharmaceuticals: Superior Efficacy Drives Vonoprazan Growth - Seeking Alpha
- 3 months ago - Phathom Pharmaceuticals Announces First Patient Dosed in Phase 2 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE) - GlobeNewsWire
- 3 months ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Phathom Pharmaceuticals, Inc. (PHAT) Q3 2025 Earnings Call Transcript - Seeking Alpha